# Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).

> **NCT00404261** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 132 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone/Salmeterol HFA

## Key facts

- **NCT ID:** NCT00404261
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404261, "Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00404261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*